Brown, Z. J., Yu, S. J., Heinrich, B., Ma, C., Fu, Q., Sandhu, M., . . . Greten, T. F. (2018). Indoleamine 2,3-dioxygenase provides adaptive resistance to immune checkpoint inhibitors in hepatocellular carcinoma. Cancer Immunol Immunother.
Trích dẫn kiểu ChicagoBrown, Zachary J., et al. "Indoleamine 2,3-dioxygenase Provides Adaptive Resistance to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma." Cancer Immunol Immunother 2018.
Trích dẫn MLABrown, Zachary J., et al. "Indoleamine 2,3-dioxygenase Provides Adaptive Resistance to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma." Cancer Immunol Immunother 2018.
Cảnh báo: Các trích dẫn này có thể không phải lúc nào cũng chính xác 100%.